# FDA Inspection 1200252 - Unimed Pharmaceuticals, Inc. - February 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/unimed-pharmaceuticals-inc/9cf4df25-31a3-45c2-bc65-8315c0b79295
Source feed: FDA_Inspections

> FDA Inspection 1200252 for Unimed Pharmaceuticals, Inc. on February 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200252
- Company Name: Unimed Pharmaceuticals, Inc.
- Inspection Date: 2023-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1052018 - 2018-05-16](https://www.keypedia.com/records/fda_inspections/unimed-pharmaceuticals-inc/04531d23-05aa-47b1-83ef-53719babbaa9)

Company: https://www.keypedia.com/companies/unimed-pharmaceuticals-inc/0a411cb1-2d5b-4ecd-b601-a15549196dd3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c